ZOCGER REPORT AT THE DEPARTMENT OF MUSCULOSKELETAL MEDICINE - MILITARY CENTRAL HOSPITAL

On October 14, 2026, at the Department of Internal Medicine, Orthopedics, and Rheumatology of Military Central Hospital, Medbolide Pharma JSC successfully organized the “Workshop Introducing ZOCGER (Capsaicin 0.075%)—A New Therapy for Acute and Chronic Pain.”

Through the workshop, doctors had the opportunity to gain a deeper understanding of ZOCGER, which contains 0.075% capsaicin—a compound that inactivates the TRPV1 pain receptor when used at high concentrations or repeatedly—thereby blocking the transmission of pain and itch signals. Key highlights include:

• A new mechanism of pain relief
• Minimized side effects
• Combination therapy to enhance pain control

Following the seminar, the doctors spoke highly of the ZOCGER product (Capsaicin 0.075%). Medbolide would like to express its gratitude to the doctors and hopes to continue partnering with the Department of Musculoskeletal Medicine at Military Central Hospital to provide effective treatment solutions and improve patients’ quality of life.